Selecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Studies showed that specific probiotics might provide therapeutic benefits in inflammatory bowel disease. However, a rigorous screening of new probiotics is needed to study possible adverse interactions with the host, particularly when intended for administration to individuals with certain health risks. In this context, the objective of this study was to investigate the role of three lactobacilli (LAB) on intestinal inflammation and bacterial translocation using variations of the mouse model of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced acute colitis. We first compared the in vitro ability of LAB to survive gastrointestinal tract (GIT) conditions and their ability to persist in the GIT of mice following daily oral administration. As a control, we included a nonprobiotic Lactobacillus paracasei strain, previously isolated from an endocarditis patient. Feeding high doses of LAB strains to healthy and to TNBS-treated mice did not induce any detrimental effect or abnormal translocation of the bacteria. Oral administration of Lactobacillus salivarius Ls-33 had a significant preventive effect on colitis in mice, while Lactobacillus plantarum Lp-115 and Lactobacillus acidophilus NCFM did not. None of the three selected LAB strains translocated to extraintestinal organs of TNBS-treated mice. In contrast, L. paracasei exacerbated colitis under severe inflammatory conditions and translocated to extraintestinal organs. This study showed that evaluations of the safety and functionality of new probiotics are recommended. We conclude that not all lactobacilli have similar effects on intestinal inflammation and that selected probiotics such as L. salivarius Ls-33 may be considered in the prevention or treatment of intestinal inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285 · cited 1×
“This evidence has led to an increased use of probiotic preparations in the therapy of IBD that usually contain lactobacilli, bifidobacteria, or Escherichia coli strains (8, 14, 18).”
BackgroundCharteris, Kelly, Morelli, & Collins (1998) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.1998.00407.x · Cited by 774 · cited 1×
“8, respectively, as described previously (5).”
Probiotic potential of Lactobacillus strains isolated from dairy products
Maragkoudakis, P. A., Zoumpopoulou, G., Miaris, C., Kalantzopoulos, G., Pot, B., & Tsakalidou, E. (2006) · International Dairy Journal · doi:10.1016/j.idairyj.2005.02.009 · Cited by 618 · cited 2×
“E. coli strain TG1 was used as a positive control, and the nonadhesive L. plantarum strain V299 adh was used as a negative control as described previously ( 24 ).”
BackgroundMethodSelf-citationLactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599
Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380455 · Cited by 426 · cited 1×
“However, the possible involvement of certain LAB strains was described in cases of sepsis, endocarditis, or bacteremia, mostly in association with a severe underlying disease or detrimental condition (21, 35, 36).”
BackgroundVesa, Pochart, & Marteau (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00763.x · Cited by 200 · cited 1×
“GIT to that of L. plantarum NCIMB8826 because its survival and persistence in mouse and human GITs was well documented (33, 43 ).”
BackgroundEffects of probiotics on the gastrointestinal tract
Snelling, A. M. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000182103.32504.e3 · Cited by 46
Cited by
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Lactobacillus plantarum and Its Probiotic and Food Potentialities
Seddik, H. A., Bendali, F., Gancel, F., Fliss, I., Spano, G., & Drider, D. (2017) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9264-z · Cited by 418
The food-gut axis: lactic acid bacteria and their link to food, the gut microbiome and human health
De Filippis, F., Pasolli, E., & Ercolini, D. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa015 · Cited by 303
Characterization and probiotic potential of Lactobacillus plantarum strains isolated from cheeses
Zago, M., Fornasari, M. E., Carminati, D., Burns, P., Suàrez, V., Vinderola, G., Reinheimer, J., & Giraffa, G. (2011) · Food Microbiology · doi:10.1016/j.fm.2011.02.009 · Cited by 298
The microbiological efficacy of decontamination methodologies for fresh produce: A review
Goodburn, C., & Wallace, C. A. (2013) · Food Control · doi:10.1016/j.foodcont.2012.12.012 · Cited by 293
Metadata
- Authors
- Daniel, C., Poiret, S., Goudercourt, D., Dennin, V., Leyer, G., & Pot, B.
- Venue
- Applied and Environmental Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2006-09
- Volume
- 72
- Issue
- 9
- Pages
- 5799-5805
- ISSN
- 0099-2240 (ISSN-L)
- 1098-5336
- OpenAlex
- W2164525350
- Cited by
- 131
- References
- 7
- FWCI
- 16.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model. https://app.cochat.ai/papers/10.1128/aem.00109-06
- The paper
- Daniel, C., Poiret, S., Goudercourt, D., Dennin, V., Leyer, G., & Pot, B. (2006). Selecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model. Applied and Environmental Microbiology. https://doi.org/10.1128/aem.00109-06
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.